Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

A novel influenza virus neuraminidase inhibitor AV5027.

Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Leneva IA, Borisova OV.

Antiviral Res. 2013 Oct 24. pii: S0166-3542(13)00298-2. doi: 10.1016/j.antiviral.2013.10.008. [Epub ahead of print]

PMID:
24513312
2.

A novel influenza virus neuraminidase inhibitor AV5027.

Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Leneva IA, Borisova OV.

Antiviral Res. 2013 Dec;100(3):698-708.

PMID:
24416774
3.

Novel oral anti-influenza prodrug candidate AV5075S.

Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Shevkun NA, Mokrushina OV, Nevolina OO, Karapetian RN, Leneva IA, Fedyakina IT, Veselov MS.

J Antimicrob Chemother. 2014 May;69(5):1311-24. doi: 10.1093/jac/dkt507. Epub 2014 Jan 15.

4.

QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.

Zheng M, Yu K, Liu H, Luo X, Chen K, Zhu W, Jiang H.

J Comput Aided Mol Des. 2006 Sep;20(9):549-66. Epub 2006 Nov 11.

PMID:
17103017
5.

Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.

Liu Y, Jing F, Xu Y, Xie Y, Shi F, Fang H, Li M, Xu W.

Bioorg Med Chem. 2011 Apr 1;19(7):2342-8. doi: 10.1016/j.bmc.2011.02.019. Epub 2011 Feb 17.

PMID:
21382719
6.

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.

Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU.

Antiviral Res. 1998 Feb;37(2):107-20.

PMID:
9588843
7.

Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.

Liu Y, Zhang L, Gong J, Fang H, Liu A, Du G, Xu W.

J Enzyme Inhib Med Chem. 2011 Aug;26(4):506-13. doi: 10.3109/14756366.2010.534732. Epub 2010 Dec 14.

PMID:
21143042
8.

Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.

Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S.

J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.

PMID:
18707092
10.

Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.

Wang Y, Wu D, Yu D, Wang Z, Tian L, Wang Y, Han W, Fang X.

J Mol Model. 2012 Aug;18(8):3445-53. doi: 10.1007/s00894-011-1349-0. Epub 2012 Jan 27.

PMID:
22278046
11.

Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.

Li L, Li Y, Zhang L, Hou T.

J Chem Inf Model. 2012 Oct 22;52(10):2715-29. doi: 10.1021/ci300375k. Epub 2012 Oct 2.

PMID:
22998323
12.

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.

Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC.

J Med Chem. 1998 Jul 2;41(14):2451-60.

PMID:
9651151
13.

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.

Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

Bioorg Med Chem. 2012 Mar 15;20(6):2152-7. doi: 10.1016/j.bmc.2012.01.026. Epub 2012 Jan 26.

PMID:
22342267
14.

Design, Synthesis, and Molecular Docking of Novel Pyrrolooxazepinediol Derivatives with Anti-Influenza Neuraminidase Activity.

El-Nezhawy AO, Eweas AF, Maghrabi IA, Edalo AS, Abdelwahab SF.

Arch Pharm (Weinheim). 2015 Sep 17. doi: 10.1002/ardp.201500209. [Epub ahead of print]

PMID:
26377573
15.

In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.

Molla A, Kati W, Carrick R, Steffy K, Shi Y, Montgomery D, Gusick N, Stoll VS, Stewart KD, Ng TI, Maring C, Kempf DJ, Kohlbrenner W.

J Virol. 2002 Jun;76(11):5380-6.

16.

Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).

Hitaoka S, Matoba H, Harada M, Yoshida T, Tsuji D, Hirokawa T, Itoh K, Chuman H.

J Chem Inf Model. 2011 Oct 24;51(10):2706-16. doi: 10.1021/ci2002395. Epub 2011 Sep 13.

PMID:
21870866
17.

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

Mitrasinovic PM.

Biophys Chem. 2009 Mar;140(1-3):35-8. doi: 10.1016/j.bpc.2008.11.004. Epub 2008 Nov 20.

PMID:
19117662
18.

Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.

Wang GT, Chen Y, Wang S, Gentles R, Sowin T, Kati W, Muchmore S, Giranda V, Stewart K, Sham H, Kempf D, Laver WG.

J Med Chem. 2001 Apr 12;44(8):1192-201.

PMID:
11312919
19.

In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.

Hussain Basha S, Prasad RN.

BMC Res Notes. 2012 Feb 17;5:105. doi: 10.1186/1756-0500-5-105.

20.

Combinatorial design of avian influenza neuraminidase inhibitors containing pyrrolidine core with a reduced susceptibility to viral drug resistance.

Rungrotmongkol T, Udommaneethanakit T, Frecer V, Miertus S.

Comb Chem High Throughput Screen. 2010 Mar;13(3):268-77.

PMID:
20015013
Items per page

Supplemental Content

Write to the Help Desk